# Find your payout — Dupixent (dupilumab) litigation

> Illustrative screening flow for Dupixent (dupilumab) litigation. Not legal advice or a guarantee of eligibility.

**Canonical URL:** https://drugsmonitor.com/settlement-calculator/dupixent-dupilumab-lawsuit
**Case overview:** https://drugsmonitor.com/case/dupixent-dupilumab-lawsuit
**Litigation status:** Emerging
**Last updated:** 2026-06-11

## What this tool does

The find-your-payout screener asks screening questions and may show an illustrative range with disclaimers before optional intake. Results are not predictions.

## Clinical context (summary)

Dupilumab is a biologic that blocks IL-4/IL-13 signaling and is used for atopic dermatitis, asthma, and other conditions. Post-marketing reports and litigation discussions have included ocular surface disease, keratitis, and vision-related harms in some patients—defendants dispute causation and labeling adequacy.

---

*DrugsMonitor.com is not a law firm.*